Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Bone Marrow Transplantation|June 20, 2003
Hematopoietic stem cell gene therapy: progress toward therapeutic targetsJ L Vollweiler, S P Zielske, J S Reese, et al.Oncogene|September 6, 2001
Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient miceJ S Reese, E Allay, S L GersonJournal of Hematotherapy & Stem Cell Research|May 3, 2000
Human mesenchymal stem cells provide stromal support for efficient CD34+ transductionJ S Reese, O N Koç, S L GersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomideJ S Reese, B M Davis, L Liu, et al.Cancer Gene Therapy|July 27, 1999
Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transferO N Koç, J S Reese, E M Szekely, et al.Journal of Hematotherapy & Stem Cell Research|March 29, 2001
MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposureJ S Reese, X Qin, C B Ballas, et al.Oncogene|November 20, 1997
Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferaseE Allay, J S Reese, E A McGuire, et al.Proceedings of the National Academy of Sciences of the United States of America|April 11, 2001
Applied molecular evolution of O6-benzylguanine-resistant DNA alkyltransferases in human hematopoietic cellsB M Davis, L P Encell, S P Zielske, et al.Human Gene Therapy|May 1, 1999
DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenograftsO N Koç, J S Reese, B M Davis, et al.Seminars in Oncology|February 1, 1996
Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy toleranceO N Koç, J A Allay, K Lee, et al.Pageof 14